A comprehensive population-based study comparing the phenotype and genotype in a pretherapeutic screen of dihydropyrimidine dehydrogenase deficiency

BACKGROUND: Pretherapeutic screening for dihydropyrimidine dehydrogenase (DPD) deficiency is recommended or required prior to the administration of fluoropyrimidine-based chemotherapy. However, the best strategy to identify DPD-deficient patients remains elusive. METHODS: Among a nationwide cohort o...

Descripción completa

Detalles Bibliográficos
Autores principales: Pallet, Nicolas, Hamdane, Salma, Garinet, Simon, Blons, Hélène, Zaanan, Aziz, Paillaud, Elena, Taieb, Julien, Laprevote, Olivier, Loriot, Marie-Anne, Narjoz, Céline
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462856/
https://www.ncbi.nlm.nih.gov/pubmed/32595208
http://dx.doi.org/10.1038/s41416-020-0962-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462856/
https://www.ncbi.nlm.nih.gov/pubmed/32595208
http://dx.doi.org/10.1038/s41416-020-0962-z

Ejemplares similares